Stocks Explorer
Stocks
Sectors
Search
NERVGEN PHARMA CORP.(9UA) News
Profile
Chart
News
Analysis
9UA price today
by TradingView
Date
Title
Jan 2
NervGen Completes Enrollment in Chronic Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
‹ Prev
Page
of 1
Next ›